Literature DB >> 32732836

Delayed Implantation of Pumped Kidneys Decreases Renal Allograft Futility in Combined Liver-Kidney Transplantation.

Keri E Lunsford1, Vatche G Agopian2, Stephanie G Yi1, Duc T M Nguyen3, Edward A Graviss3, Michael P Harlander-Locke2, Ashish Saharia1, Fady M Kaldas2, Constance M Mobley1, Ali Zarrinpar4, Mark J Hobeika1, Jeffrey L Veale5, Hemangshu Podder1, Douglas G Farmer2, Richard J Knight1, Gabriel M Danovitch6, H Albin Gritsch5, Xian C Li1, R Mark Ghobrial1, Ronald W Busuttil2, A Osama Gaber1.   

Abstract

BACKGROUND: Combined liver-kidney transplantation (CLKT) improves survival for liver transplant recipients with renal dysfunction; however, the tenuous perioperative hemodynamic and metabolic milieu in high-acuity CLKT recipients increases delayed graft function and kidney allograft failure. We sought to analyze whether delayed KT through pumping would improve kidney outcomes following CLKT.
METHODS: A retrospective analysis (University of California Los Angeles [n = 145], Houston Methodist Hospital [n = 79]) was performed in all adults receiving CLKT at 2 high-volume transplant centers from February 2004 to January 2017, and recipients were analyzed for patient and allograft survival as well as renal outcomes following CLKT.
RESULTS: A total of 63 patients (28.1%) underwent delayed implantation of pumped kidneys during CLKT (dCLKT) and 161 patients (71.9%) received early implantation of nonpumped kidneys during CLKT (eCLKT). Most recipients were high-acuity with median biologic model of end-stage liver disease (MELD) score of, 35 for dCLKT and 34 for eCLKT (P = ns). Pretransplant, dCLKT had longer intensive care unit stay, were more often intubated, and had greater vasopressor use. Despite this, dCLKT exhibited improved 1-, 3-, and 5-year patient and kidney survival (P = 0.02) and decreased length of stay (P = 0.001), kidney allograft failure (P = 0.012), and dialysis duration (P = 0.031). This reduced kidney allograft futility (death or continued need for hemodialysis within 3 mo posttransplant) for dCLKT (6.3%) compared with eCLKT (19.9%) (P = 0.013).
CONCLUSIONS: Delayed implantation of pumped kidneys is associated with improved patient and renal allograft survival and decreased hospital length of stay despite longer kidney cold ischemia. These data should inform the ethical debate as to the futility of performing CLKT in high-acuity recipients.

Entities:  

Mesh:

Year:  2020        PMID: 32732836     DOI: 10.1097/TP.0000000000003040

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Is Prioritization of Kidney Allografts to Combined Liver-Kidney Recipients Appropriate? PRO.

Authors:  Tiffany T Truong; Mitra K Nadim
Journal:  Kidney360       Date:  2021-10-15

2.  Predictors of Kidney Delayed Graft Function and Its Prognostic Impact following Combined Liver-Kidney Transplantation: A Recent Single-Center Experience.

Authors:  Paolo Vincenzi; Jeffrey J Gaynor; Rodrigo Vianna; Gaetano Ciancio
Journal:  J Clin Med       Date:  2022-05-11       Impact factor: 4.964

3.  Rapid reduction of high-level pre-formed donor-specific antibodies after simultaneous liver-kidney transplantation: a report of two cases.

Authors:  Christina Lai; Allyson Newman; Jane Mawson; Frederika Abou-Daher; Narelle Watson; Avik Majumdar; Kate Wyburn; Steve Chadban; David Gracey
Journal:  BMC Nephrol       Date:  2020-02-12       Impact factor: 2.388

4.  Trends and Outcomes of Hypothermic Machine Perfusion Preservation of Kidney Allografts in Simultaneous Liver and Kidney Transplantation in the United States.

Authors:  Alex Chang; Douglas E Schaubel; Melissa Chen; Peter L Abt; Therese Bittermann
Journal:  Transpl Int       Date:  2022-03-14       Impact factor: 3.782

5.  Impact of Recipient Age in Combined Liver-Kidney Transplantation: Caution Is Needed for Patients ≥70 Years.

Authors:  Burcin Ekser; William C Goggins; Jonathan A Fridell; Plamen Mihaylov; Richard S Mangus; Andrew J Lutz; Daiki Soma; Marwan S Ghabril; Marco A Lacerda; John A Powelson; Chandrashekhar A Kubal
Journal:  Transplant Direct       Date:  2020-05-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.